Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Malnutrition 1 Hyperphagia 1 Hematopoietic and Lymphatic System Neoplasm 1 Esophageal Neoplasms 1

Interventions

Oxaliplatin 29 Fluorouracil 23 Capecitabine 19 pembrolizumab 17 Nivolumab 17 Leucovorin 16 Docetaxel 10 Paclitaxel 9 Drug Therapy 9 Cisplatin 9 fludarabine 8 Trastuzumab 8 S 1 (combination) 8 Cyclophosphamide 8 Specimen Handling 7 trastuzumab deruxtecan 6 Bevacizumab 6 Magnetic Resonance Spectroscopy 5 Biopsy 5 zolbetuximab 4 Irinotecan 4 Carboplatin 4 zimberelimab 3 sintilimab 3 olaparib 3 fludarabine phosphate 3 durvalumab 3 atezolizumab 3 aldesleukin 3 XELOX 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × Parenteral Nutrition × 90 days × Clear all

NCT07604857 2026-05-22

BRIDGE-GC

The Catholic University of Korea

Phase NA Completed

Gastrointestinal

Hyperphagia, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡